Stem Cell Therapy

CALGARY, Alberta, Oct. 9, 2025 — Hemostemix has filed for Institutional Review Board (IRB) approval of its Phase 1...

San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...